Post by
Humanist on Sep 28, 2020 5:18pm
RTI provides update on 1st qtr finacial statment & execs
Radient Technologies Inc. Provides Update on Filing of First Quarter Financial Statements and Executive Compensation Disclosure
September 28, 2020 17:00 ET | Source: Radient Technologies Inc
EDMONTON, Alberta, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), announces that the Company will be relying on the temporary 45 day extension to the filing deadline of its financial statements and management’s discussion and analysis (“MD&A”) for the quarter ended June 30, 2020 granted by the Alberta Securities Commission (“ASC”) in response to unprecedented challenges resulting from COVID-19.
As per National Instrument 51-102 Continuous Disclosure Obligations, the Company was to file its quarterly financial statements and MD&A by August 29, 2020. Relying on ASC Blanket Order 51-519, which provides the Company with an additional 45 days from the deadline to file, the Company expects to file its quarterly financial statements and MD&A on or before October 13, 2020.
Radient expects that the Company’s executive compensation disclosure will also be delayed. The Company will be relying on the exemption provided by s.10(1) of ASC Blanket Order 51-518 exemption to file our executive compensation disclosure on SEDAR by October 16, 2020.
The Company acknowledges that management and other insiders are subject to an insider trading black-out policy, that reflects the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions, until the second trading day after the Quarterly Filings have been disclosed.
All material business developments since the date of the Company’s filing of its annual financial statements and MD&A for the period ended March 31, 2020 have been disclosed.
About Radient
Radient Technologies is a commercial manufacturer of high quality cannabinoid based formulations, ingredients and products. Utilizing a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant, Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Please visit www.radientinc.com for more information.
SOURCE: Radient Technologies Inc.